159 related articles for article (PubMed ID: 20532795)
21. Immunohistochemical expression of OCT4 in primary central nervous system germ cell tumours.
Ngan KW; Jung SM; Lee LY; Chuang WY; Yeh CJ; Hsieh YY
J Clin Neurosci; 2008 Feb; 15(2):149-52. PubMed ID: 17997317
[TBL] [Abstract][Full Text] [Related]
22. Paradoxical Expression of R-10G-reactive Antigen in Human Testicular Embryonal Carcinoma.
Muramoto A; Inamura S; Hoshino H; Terada N; Kobayashi M
J Histochem Cytochem; 2023 Oct; 71(10):555-563. PubMed ID: 37675782
[TBL] [Abstract][Full Text] [Related]
23. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer.
Koster R; di Pietro A; Timmer-Bosscha H; Gibcus JH; van den Berg A; Suurmeijer AJ; Bischoff R; Gietema JA; de Jong S
J Clin Invest; 2010 Oct; 120(10):3594-605. PubMed ID: 20811155
[TBL] [Abstract][Full Text] [Related]
25. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
[TBL] [Abstract][Full Text] [Related]
26. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
27. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Looijenga LH; Stoop H; de Leeuw HP; de Gouveia Brazao CA; Gillis AJ; van Roozendaal KE; van Zoelen EJ; Weber RF; Wolffenbuttel KP; van Dekken H; Honecker F; Bokemeyer C; Perlman EJ; Schneider DT; Kononen J; Sauter G; Oosterhuis JW
Cancer Res; 2003 May; 63(9):2244-50. PubMed ID: 12727846
[TBL] [Abstract][Full Text] [Related]
28. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
[TBL] [Abstract][Full Text] [Related]
29. TCF3 inhibits F9 embryonal carcinoma growth by the down-regulation of Oct4.
Lin G; Zhao L; Yin F; Lan R; Li L; Zhang X; Zhang H; Yang B
Oncol Rep; 2011 Oct; 26(4):893-9. PubMed ID: 21725619
[TBL] [Abstract][Full Text] [Related]
30. Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human non-seminomatous germ cell tumour cell lines.
Dunn TA; Schmoll HJ; Rie C; Hartmann K; Casper J
J Cancer Res Clin Oncol; 1998; 124(8):435-43. PubMed ID: 9750020
[TBL] [Abstract][Full Text] [Related]
31. Protein expression of the transcription factors DMRT1, TCLF5, and OCT4 in selected germ cell neoplasms of the testis.
Roth LM; Michal M; Michal M; Cheng L
Hum Pathol; 2018 Dec; 82():68-75. PubMed ID: 30067948
[TBL] [Abstract][Full Text] [Related]
32. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract][Full Text] [Related]
33. Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer.
Dunn TA; Schmoll HJ; Grünwald V; Bokemeyer C; Casper J
Anticancer Drugs; 1996 Sep; 7(7):795-9. PubMed ID: 8949993
[TBL] [Abstract][Full Text] [Related]
34. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract][Full Text] [Related]
36. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
37. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
38. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
Moran CA; Suster S; Koss MN
Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
[TBL] [Abstract][Full Text] [Related]
39. Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry.
Jones TD; MacLennan GT; Bonnin JM; Varsegi MF; Blair JE; Cheng L
Am J Surg Pathol; 2006 Nov; 30(11):1427-31. PubMed ID: 17063084
[TBL] [Abstract][Full Text] [Related]
40. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
Nogales FF; Prat J; Schuldt M; Cruz-Viruel N; Kaur B; D'Angelo E; Matias-Guiu X; Vidal A; McCluggage WG; Oosterhuis JW
Histopathology; 2018 Mar; 72(4):634-647. PubMed ID: 29106744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
